Skip to main content
. 2011 Sep 2;11:385. doi: 10.1186/1471-2407-11-385

Table 4.

Tumor response by prior regimen in patients treated as second-line

Tumor Response Prior regimen (N = 20)

IP FP DP NP
Complete response 0 0 0 1
Partial response 4 2 1 2
Stable disease 1 1 2 1
Progressive disease 2 0 3 0
Total 7 3 6 4

Abbreviations: IP, Irinotecan/cisplatin; FP, 5-fluorouracil/cisplatin; DP, docetaxel/cisplatin; NP, vinorelbine/cisplatin.